What is the Kyorin Pharmaceutical Co., Ltd. stock price forecast?

Kyorin Pharmaceutical Co., Ltd. is currently trading at ¥1,142. View real-time AI analysis on Alpha Lenz.

What is Kyorin Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Kyorin Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Kyorin Pharmaceutical Co., Ltd.'s P/E ratio?

Kyorin Pharmaceutical Co., Ltd.'s P/E ratio is 7.2.

Kyorin Pharmaceutical Co., Ltd.

JPX · 4569

¥1,142-8(-0.70%)Market closed

Ask about Kyorin Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Kyorin Pharmaceutical Co., Ltd. trades at a P/E of 7.2 (undervalued) with modest ROE of 6.8%.”

Ask for details →

Company Overview

Kyorin Pharmaceutical Co., Ltd. is a renowned Japanese pharmaceutical company committed to developing and marketing innovative healthcare products. The company's primary function is to produce pharmaceuticals that address various medical needs, focusing on therapeutic areas like respiratory medicine, urology, and infectious diseases. As a key player in the healthcare industry, Kyorin not only supports patient health but also contributes to medical advancements through extensive research and development. Kyorin Pharmaceutical impacts the healthcare sector by supplying essential drugs and treatments, thereby enhancing patient outcomes and public health standards. Established in 1923 and headquartered in Tokyo, Japan, the company operates with a global outlook, exporting its products to various international markets. Kyorin's commitment to innovation and quality makes it a significant entity in the pharmaceutical market, continuously working to meet the evolving demands of healthcare professionals and patients worldwide.

CEOMr. Yutaka Ogihara

Websitehttps://www.kyorin-pharm.co.jp

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1,998

Company Statistics

FY 2025

Profile

¥65,601,644,124Market Cap

¥130,087,000,000Revenue

0.00Shares Out

1,998Employees

Margins

45.77%Gross

13.85%EBITDA

9.66%Operating

9.82%Pre-Tax

6.98%Net

Valuation

7.22P/E

0.48P/B

0.50EV/Sales

4.39EV/EBITDA

-23.54P/FCF

Growth (CAGR)

7.22%Rev 3Yr

3.41%Rev 5Yr

35.89%Op Inc 3Yr

10.87%Op Inc 5Yr

32.21%Net Inc 3Yr

8.12%Net Inc 5Yr

Returns

4.89%ROA

6.81%ROE

6.97%ROIC

Financial Health

¥15,021,000,000Cash & Cash Equivalents

¥42,313,000,000Net Debt

42.07%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Kyorin Pharmaceutical Co., Ltd. trades at a P/E of 7.2 (undervalued) with modest ROE of 6.8%.”

Ask for details →

Frequently Asked Questions

Kyorin Pharmaceutical Co., Ltd. (ticker: 4569) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,998 employees. Market cap is $65.6B.

The current price is 1,142 with a P/E ratio of 7.22x and P/B of 0.48x.

ROE is 6.81% and operating margin is 9.66%. Annual revenue is $130.1B.